Jailendra Singh Analyst PerformanceManaging Director (Senior Equity Research Analyst Covering Healthcare Technology/Digital Health/CROs at Truist FinancialJailendra Singh is a stock analyst at Truist Financial focused in the medical sector, covering 25 publicly traded companies. Over the past year, Jailendra Singh has issued 44 stock ratings, including buy and hold recommendations. While full access to Jailendra Singh's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jailendra Singh's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings79 Last 6 YearsBuy Recommendations60.56% 43 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution71RatingsDistribution of strong buy, buy, hold, and sell ratings by Jailendra Singh.RatingPercentageCount Strong Buy0.0%0 ratings Buy60.6%43 ratings Hold38.0%27 ratings Sell1.4%1 ratingsOut of 71 total stock ratings issued by Jailendra Singh at Truist Financial, the majority (60.6%) have been Buy recommendations, followed by 38.0% Hold and 1.4% Sell.Best & Worst CallsBest Call000.0%MCKJan 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%EVHApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE52.0% of companies on NYSE13 companiesNASDAQ48.0% of companies on NASDAQ12 companiesJailendra Singh, an analyst at Truist Financial, currently covers 25 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical19 companies76.0%Computer and Technology2 companies8.0%Finance2 companies8.0%Services1 company4.0%Manufacturing1 company4.0%Jailendra Singh of Truist Financial specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Finance companies.Coverage IndustriesIndustryPercentageMEDICAL INFO SYS7 companies28.0%MEDICAL SERVICES6 companies24.0%INTERNET SOFTWARE2 companies8.0%MED/DENTAL - SUPP2 companies8.0%MED - OUTP/HM CRE1 company4.0%SERVICES – COMPUTER PROGRAMMING AND DATA PROCESSING1 company4.0%MED INSTRUMENTS1 company4.0%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company4.0%MED - BIOMED/GENE1 company4.0%INS - LIFE1 company4.0%INS - BROKERS1 company4.0%MED PRODUCTS1 company4.0% Jailendra Singh's Ratings History at Truist Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsASTHAstrana Health5/14/2026Boost Price Target$39.16$47.00Buy$0.0000.00% ROIDOCSDoximity5/14/2026Reiterated Rating$17.74$19.00Hold$0.0000.00% ROIPGNYProgyny5/11/2026Boost Price Target$22.71$30.00Buy$0.0000.00% ROIHNGEHinge Health5/6/2026Set Price Target$54.05$79.00$0.0000.00% ROIDOCSDoximity4/20/2026Reiterated Rating$24.72$29.00Hold$0.0000.00% ROIPHRPhreesia3/31/2026Reiterated Rating$11.43$11.00Hold$0.0000.00% ROIASTHAstrana Health3/13/2026Boost Price Target$24.23$38.00Buy$0.0000.00% ROIVEEVVeeva Systems3/5/2026Reiterated Rating$192.60$262.00Buy$0.0000.00% ROIPGNYProgyny3/2/2026Lower Price Target$17.69$28.00Buy$0.0000.00% ROIPRVAPrivia Health Group3/2/2026Boost Price Target$23.75$33.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. EVHEvolent Health2/25/2026Lower Price Target$3.06$6.00Buy$0.0000.00% ROIHIMSHims & Hers Health2/24/2026Reiterated Rating$14.13$18.00Hold$0.0000.00% ROIIQVIQVIA2/19/2026Lower Price Target$164.73$245.00Buy$0.0000.00% ROIWAYWaystar2/18/2026Lower Price Target$25.14$38.00Buy$0.0000.00% ROIMEDPMedpace2/11/2026Lower Price Target$446.05$539.00Hold$0.0000.00% ROIDOCSDoximity2/6/2026Lower Price Target$33.30$37.00Buy$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$52.00Buy$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$42.72$52.00Buy$0.0000.00% ROIPHRPhreesia1/8/2026Set Price Target$16.99$24.00$0.0000.00% ROIDOCSDoximity1/8/2026Set Price Target$44.98$62.00$0.0000.00% ROIIQVIQVIA1/8/2026Boost Price Target$242.74$290.00Buy$0.0000.00% ROIICLRIcon1/8/2026Reiterated Rating$202.92$222.00Hold$0.0000.00% ROIFTREFortrea1/8/2026Set Price Target$17.49$22.00Buy$0.0000.00% ROIPGNYProgyny1/8/2026Upgrade$28.26$34.00Buy$0.0000.00% ROIFTREFortrea1/8/2026Upgrade$17.44$22.00Buy$0.0000.00% ROIPHRPhreesia12/10/2025Set Price Target$15.95$29.00$0.0000.00% ROIPRVAPrivia Health Group11/10/2025Reiterated Rating$23.34$31.00Buy$0.0000.00% ROIEVHEvolent Health11/10/2025Lower Price Target$5.15$10.00Buy$0.0000.00% ROIIQVIQVIA10/29/2025Reiterated Rating$219.81$265.00Buy$0.0000.00% ROIMEDPMedpace10/27/2025Set Price Target$595.64$555.00$0.0000.00% ROIPHRPhreesia9/5/2025Boost Price Target$28.09$36.00Buy$0.0000.00% ROIHIMSHims & Hers Health8/18/2025Lower Price Target$44.81$37.00Hold$0.0000.00% ROIICLRIcon7/25/2025Boost Price Target$185.50$234.00Buy$0.0000.00% ROIIQVIQVIA7/23/2025Boost Price Target$192.44$235.00Buy$0.0000.00% ROIMEDPMedpace7/23/2025Boost Price Target$449.28$436.00Hold$0.0000.00% ROIWAYWaystar7/17/2025Boost Price Target$37.48$51.00Buy$0.0000.00% ROIPGNYProgyny7/17/2025Boost Price Target$22.97$27.00Hold$0.0000.00% ROIHIMSHims & Hers Health7/17/2025Boost Price Target$51.50$48.00Hold$0.0000.00% ROIEVHEvolent Health7/17/2025Boost Price Target$11.60$16.00Buy$0.0000.00% ROIDOCSDoximity7/17/2025Boost Price Target$62.87$61.00Hold$0.0000.00% ROIIran's New Leader Just Said Something That Should Terrify Every American (Ad)Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors.Claim your free copy of The Great Gold Reset report todayHIMSHims & Hers Health6/24/2025Set Price Target$42.37$45.00$0.0000.00% ROIHNGEHinge Health6/16/2025Initiated Coverage$34.76$48.00Buy$0.0000.00% ROIPHRPhreesia5/29/2025Boost Price Target$23.93$35.00Buy$0.0000.00% ROITDOCTeladoc Health5/27/2025Lower Price Target$7.06$9.00Hold$0.0000.00% ROIDOCSDoximity5/16/2025Lower Price Target$52.39$52.00Hold$00.0000.00% ROIWAYWaystar5/7/2025Set Price Target$41.03$50.00Buy$00.0000.00% ROIMEDPMedpace4/23/2025Lower Price Target$291.25$300.00Hold$000.0000.00% ROIMEDPMedpace4/10/2025Lower Price Target$302.56$333.00Hold$000.0000.00% ROIIQVIQVIA4/10/2025Lower Price Target$157.02$216.00Buy$000.0000.00% ROIICLRIcon4/10/2025Lower Price Target$155.49$208.00Buy$000.0000.00% ROIPRVAPrivia Health Group4/10/2025Boost Price Target$23.05$28.00Buy$00.0000.00% ROIHIMSHims & Hers Health4/10/2025Lower Price Target$29.39$33.00Hold$00.0000.00% ROIGDRXGoodRx4/10/2025Lower Price Target$4.69$5.50Hold$0.0000.00% ROIEVHEvolent Health4/10/2025Lower Price Target$9.98$14.00Buy$0.0000.00% ROIDOCSDoximity4/10/2025Lower Price Target$55.59$58.00Hold$00.0000.00% ROIAMWLAmerican Well4/10/2025Lower Price Target$7.13$7.50Hold$0.0000.00% ROIASTHAstrana Health3/18/2025Lower Price Target$30.91$46.00Buy$00.0000.00% ROIWAYWaystar3/14/2025Initiated Coverage$35.27$45.00Buy$00.0000.00% ROIHIMSHims & Hers Health2/26/2025Boost Price Target$39.95$39.00Hold$00.0000.00% ROIAMWLAmerican Well2/14/2025Boost Price Target$11.62$12.00Hold$0.0000.00% ROIICLRIcon2/13/2025Lower Price Target$186.53$262.00Buy$00.0000.00% ROIIQVIQVIA2/10/2025Reiterated Rating$208.13$263.00Buy$000.0000.00% ROIASTHAstrana Health1/13/2025Lower Price Target$29.48$50.00Buy$00.0000.00% ROIVEEVVeeva Systems1/13/2025Lower Price Target$215.73$210.00Hold$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
